ARCHIVES

FDA Advisors OK Levamisole, Conditional New Tamoxifen Use

This article is from The Cancer Letter archive.

Vol. 16 No. 06 | February 9, 1990

Download PDF Visit The Full Archive

Related Articles

FDA Committee nixes Combination Guidelines, Okays New NDA Policy

January 21, 1977

More Cost-Effective To Use Cetuximab In Patients With Wild-Type KRAS Gene

August 28, 2009

Latest Statistics Show Decline In Deaths From Breast Cancer

January 13, 1995

Arsenic Compound Improves Survival Of Adults With APL

February 23, 2007

New Policy on Minor Changes in Trials Requires Halt in Patient Enrollment.

April 25, 2008

Reimbursement Of Some Anticancer Drugs Expected To Drop Sharply Under HHS Policy.

June 30, 2000